![Alexander Pickett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 9 $ am 30.04.2026
Alexander Pickett was the founder of Juvenescence Ltd., founded in 2016, where the title held was Chief Operating Officer.
Mr. Pickett is also the founder of Real Life Sciences, LLC..
Mr. Pickett is currently Director at Morphoceuticals, Inc. Formerly, Mr. Pickett was Chief Executive Officer & Director at AlphaTON Capital Corp.
from 2024 to 2025.
Education includes undergraduate studies at Harvard College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 21.07.2025 | 38 ( 0 % ) | 9 $ | 30.04.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Morphoceuticals, Inc.
 Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioelectric reprogramming services | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ALPHA COMPUTE CORP | Vorstandsvorsitzender | 03.08.2025 |
Real Life Sciences, Inc.
 Real Life Sciences, Inc. Data Processing ServicesTechnology Services Provides anonymization and redaction solutions for clinical trial data and other sensitive information | Gründer | - |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Gründer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
AlphaTON Capital Corp.
 AlphaTON Capital Corp. BiotechnologyHealth Technology Operates as an immuno oncology company | Health Technology |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Real Life Sciences, Inc.
Real Life Sciences, Inc. Data Processing ServicesTechnology Services Provides anonymization and redaction solutions for clinical trial data and other sensitive information | Technology Services |
Morphoceuticals, Inc.
Morphoceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides bioelectric reprogramming services | Commercial Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
